https://endpts.com/neubase-lays-off-60-of-employees-as-it-swaps-out-antisense-focus-for-gene-editing-tech-endorsed-by-george-church/
0
0
10/17/22 at 11:31am
Organization
Endpoints News
Author
Amber Tong
Geneticist and serial entrepreneur Dietrich Stephan had hoped that his antisense oligonucleotide platform at NeuBase Therapeutics could expand the field that Ionis pioneered to new areas. But in the end, he concluded now is not the right time to explore it. N…
Create an account
or login to join the discussion